News

XXXIX Winter School in Maj Institute of Pharmacology Polish Academy of Science XXXIX Winter School in Maj Institute of Pharmacology Polish Academy of Science XXXIX Winter School was held from 2 to 4 March 2022. The theme selected for this year’s edition was Metabolic dysfunctions and diseases of the central nervous system.
Invitation to submitmanuscripts for a Special Issue of Pharmacological Reports: Invitation to submitmanuscripts for a Special Issue of Pharmacological Reports: Pharmacological Reports is inviting manuscripts for a special issue addressing "Energy metabolism in the physiology and pathology of the central nervous system", guest-edited by Dr Katarzyna Głombik (Department of ExperimentalNeuroendocrinology IF PAS) and dr hab. Katarzyna Kuter-Nowak (Department of Neuropsychopharmacology IF PAS). Detailed information is available at https://www.springer.com/journal/43440/updates/20024462
Invitation to contribute to a Special Issue of Pharmacological Reports: “The Post-COVID Era - Advances and Challenges in Pharmacology” Invitation to contribute to a Special Issue of Pharmacological Reports: “The Post-COVID Era - Advances and Challenges in Pharmacology” Pharmacological Reports is currently inviting articles for the special issue “The Post-COVID Era - Advances and Challenges in Pharmacology”, featuring as a lead guest editor prof. Marcin Poręba (Department of ChemicalBiology and Bioimaging, Wroclaw University of Science and Technology).  Detailed information is available at https://www.springer.com/journal/43440/updates/20039974
Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project Maj Institute of Pharmacology Polish Academy of Sciences is a consortium member of the GRIEG research project entitled „Theranostic nanocarriers for drug delivery in central nervous system disorders” funded under the Norwegian Financial Mechanism 2014 – 2021. Prof. Piotr Warszyński from Jerzy Haber Institute of Catalysis and Surface Chemistry PAS is the leader of the project. Apart from IP PAS (Department of Experimental Neuroendocrinology, WP leader Prof. Władysław Lasoń)), other project partners include The Henryk Niewodniczański Institute of Nuclear Physics PAS,  SINTEF AS (Trondheim) and  Oslo University Hospital. The main project objective is to develop a new strategy to deliver neuroprotectants by applying biocompatible theranostic nanocarriers, traceable in vivo by MRI, which can cross the blood-brain barrier without imposing side effects on its normal function. Application of such neuroprotective nanocarriers can be the solution for future therapies of stroke and neurodegenerations like Alzheimer's and Parkinson's diseases.